Payden & Rygel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$57.9M |
| 2 |
T-Mobile US
TMUS
|
+$16.5M |
| 3 |
Corteva
CTVA
|
+$14.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$8.9M |
| 5 |
Hasbro
HAS
|
+$8.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold MiniShares Trust
GLDM
|
+$111M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$60.6M |
| 3 |
Wells Fargo
WFC
|
+$27.1M |
| 4 |
SS&C Technologies
SSNC
|
+$16.3M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.75% |
| 2 | Healthcare | 11.38% |
| 3 | Financials | 11.18% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 6.88% |
No holdings matched the selected filter criteria.
Similar funds
Payden & Rygel's Q1 2026 Portfolio in Review
As of Q1 2026, Payden & Rygel held 129 positions worth $1.3B, down 10% from $1.45B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Payden & Rygel withdrew a net $146M in Q1 2026, closing 15 positions and reducing 28 holdings. Its most notable exit was SPDR Gold MiniShares Trust, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Payden & Rygel opened a new position in SPDR Gold Trust worth $55.6M.
- Payden & Rygel's largest Q1 2026 buy was SPDR Gold Trust: 129,300 shares worth $55.6M.
- Payden & Rygel added most to T-Mobile US in Q1 2026, an estimated $16.5M increase.
- Payden & Rygel's biggest Q1 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $60.6M.
- Payden & Rygel fully exited SPDR Gold MiniShares Trust in Q1 2026, selling an estimated $111M.
- Payden & Rygel's ten largest holdings make up 32% of its $1.3B portfolio in Q1 2026.
- Payden & Rygel opened 14 new positions and closed 15 in Q1 2026.
- Payden & Rygel's portfolio value fell 10% quarter-over-quarter to $1.3B.
Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.